Etimizol

Etimizol (Aethimizolum; list B) - analeptic. Apply etimizol to prevent respiratory depression during anesthesia with barbiturate, for excitation of breath after anesthesia, for the prevention of postoperative pneumonia, lung atelectasis, and in psychiatry at astheno-depressive disorders, sleep disorders. Assign inside of 0.05-0.1 g 2-3 times a day; in the form of parenteral of 1.5% solution: in Vienna (enter slowly) - 2-3 ml, intramuscular injection under the skin - 4 - 5 ml. treatment under mental disorders 3-5 weeks. In overdose possible nausea, vomiting, motor excitation. Etimizol contraindicated in a state of excitement.
Method of production: powder, tablets 0.1 g; ml to 2 ml of 1.5% solution. Keep in dark place.
Cm. also Stimulants nervous activity.

Etimizol (Aethimizolum; list B) - respiratory analeptic Central action; dimethylamide 1-ethyl-4,5-imidazol-dicarboxylic acid. The peculiarity of the effect of etimizol is the combination of stimulating action at the subcortex and depressive effect on the brain cortex.
Along with the stimulation of the respiratory centre etimizol has a sedative effect, increases of narcotic analgesic substances. Etimizol used to prevent respiratory depression during anesthesia with barbiturate, for excitation of breath after anesthesia, prevention of pneumonia in the postoperative period, when lung atelectasis. Assign inside of 0.05-0.1 g 3 times a day; parenteral 1.5% solution on 0,03-0,045 g in Vienna (slowly); intramuscular and subcutaneous 0.06-0,075 g
Etimizol used for the treatment of mental diseases, accompanied by anxiety, astheno-depressive disorders, sleep disorders and to potentiation of sleeping pills. In the treatment of mental diseases the preparation is administered inside of 0.05-0.1 g 3 times a day; treatment 3 to 5 weeks. Release etimizol powders and tablets 0.1 g and in the sealed to 2 ml of 1.5% solution.
Cm. also Stimulants nervous activity.